Status:
COMPLETED
Quadratus Lumborum Block Reduced Postpartum Uterine Pain After Virginal Childbirth
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Quadratus Lumborum Nerve Block
Postpartum Cramping
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
With the continuous advancement of ultrasonic technology, nerve block in which drugs are injected into the periphery of the target nerve through ultrasonic guidance has become the mainstream method fo...
Eligibility Criteria
Inclusion
- Females over twenty years of age
- Maternal vaginal delivery
- Postpartum moderate to severe pain with uterine contractions (Numerical Pain Scale (NRS) ≥ 4 points) after delivery.
- Subject's consent signed by the subject
Exclusion
- Severe coagulation abnormalities (PLT\<100000、INR\>1.2、PT\>13)
- Infection of the epidermis at the anticipated relevant site of injection
- Allergy to local anesthetics
- Allergy to or abuse of pain control medications
- Episiotomy is more painful than uterine contractions
- Inability to cooperate with associated pain assessment
- Body Mass Index (BMI) ≧ 35 kg/m2
Key Trial Info
Start Date :
May 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT05371015
Start Date
May 12 2022
End Date
August 31 2022
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital (Linkou)
Taoyuan, Taiwan, 33305